Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Frontiers in Surgery

Hydrogel and scaffold strategies for talar osteochondral repair: biofabrication, ankle biomechanics, and clinical translation

  1. 1Department of Emergency, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China
  2. 2Department of Foot and Ankle Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China

Abstract

Osteochondral lesions of the talus combine focal cartilage injury with variable subchondral bone damage in a small, highly loaded joint, making successful biomaterial translation dependent on more than regenerative capacity alone. This review examines hydrogel, scaffold, and biofabrication strategies for talar osteochondral repair through the combined lenses of ankle biomechanics, spatial construct design, and clinical feasibility. Defect containment, shoulder involvement, cystic depth, instability, and alignment alter the requirements for conformal filling, wet-field retention, cyclic compression and shear tolerance, and cartilage-bone anchorage. Recent biofabrication approaches, including gradient and multilayer scaffolds, 3D-printed architectures, decellularized extracellular-matrix hydrogels, directional microchannels, and adhesive or bioactive systems, provide increasing control over spatial organization and mechanical transitions, but most remain preclinical. Human studies support the feasibility of matrix- and scaffold-assisted talar repair, including autologous matrix-induced chondrogenesis, collagen- and hyaluronic acid-based platforms, cell-supported constructs, and related one-step procedures; however, heterogeneous lesion selection, concomitant bone grafting, instability correction, rehabilitation, imaging, and follow-up limit direct material-level comparisons. The central translational question is whether a material architecture addresses the dominant mechanical and surgical requirements of a defined talar lesion. Evaluation should therefore integrate wet-field handling, edge and interface stability, cyclic loading, bone-side integration, degradation under load, manufacturing reproducibility, and lesion-stratified clinical outcomes.

Related

  1. Multifunctional hydrogel scaffolds for endogenous osteochondral regeneration
    Ling Zhang, Xuan Liu, Jinping Liang +8
    Regenerative therapyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. A Systematic Review of Aptamer‐Based Alginate‐Agarose Hydrogel Strategies for Inhibiting Keloid Fibrosis and Hypertrophic Scarring
    Xiaorui Hu, Nur Azida Mohd Nasir, Shazana Hilda Shamsuddin +2
    Journal of cosmetic dermatologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Hydrogel-based delivery of extracellular vesicles for skin wound healing: design strategies, therapeutic mechanisms, and translational perspectives
    Yuqiu Jin, Jun Lu, Jingping Wu +3
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A
    Haonan Zhu, Xiao Ni, Zhe Yu +7
    Journal of Pharmaceutical AnalysisPeer-reviewedCC BYFull text3 citedPharmacology & toxicologyDOAJ
  5. New strategies for the treatment of tuberculosis: research progress and clinical translation in immune modulation and inflammation control
    Shihao Du, Lulu Zhen, Ji Zhou +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefEurope PMCPMC
BibTeX
@article{zhu2026hydrogel,
  title = {{Hydrogel and scaffold strategies for talar osteochondral repair: biofabrication, ankle biomechanics, and clinical translation}},
  author = {Qi Zhu and Zhengyu Liu and Beibei Chen and Jun Cui},
  journal = {Frontiers in Surgery},
  year = {2026},
  month = oct,
  doi = {10.3389/fsurg.2026.1970956},
  url = {https://doi.org/10.3389/fsurg.2026.1970956},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Hydrogel and scaffold strategies for talar osteochondral repair: biofabrication, ankle biomechanics, and clinical translation
AU  - Qi Zhu
AU  - Zhengyu Liu
AU  - Beibei Chen
AU  - Jun Cui
PY  - 2026
DA  - 2026/10/22
JO  - Frontiers in Surgery
DO  - 10.3389/fsurg.2026.1970956
UR  - https://doi.org/10.3389/fsurg.2026.1970956
AB  - Osteochondral lesions of the talus combine focal cartilage injury with variable subchondral bone damage in a small, highly loaded joint, making successful biomaterial translation dependent on more than regenerative capacity alone. This review examines hydrogel, scaffold, and biofabrication strategies for talar osteochondral repair through the combined lenses of ankle biomechanics, spatial construct design, and clinical feasibility. Defect containment, shoulder involvement, cystic depth, instability, and alignment alter the requirements for conformal filling, wet-field retention, cyclic compression and shear tolerance, and cartilage-bone anchorage. Recent biofabrication approaches, including gradient and multilayer scaffolds, 3D-printed architectures, decellularized extracellular-matrix hydrogels, directional microchannels, and adhesive or bioactive systems, provide increasing control over spatial organization and mechanical transitions, but most remain preclinical. Human studies support the feasibility of matrix- and scaffold-assisted talar repair, including autologous matrix-induced chondrogenesis, collagen- and hyaluronic acid-based platforms, cell-supported constructs, and related one-step procedures; however, heterogeneous lesion selection, concomitant bone grafting, instability correction, rehabilitation, imaging, and follow-up limit direct material-level comparisons. The central translational question is whether a material architecture addresses the dominant mechanical and surgical requirements of a defined talar lesion. Evaluation should therefore integrate wet-field handling, edge and interface stability, cyclic loading, bone-side integration, degradation under load, manufacturing reproducibility, and lesion-stratified clinical outcomes.
SN  - 2296-875X
ER  -